SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 197 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,151,750 | +82.8% | 235,000 | +235.7% | 0.08% | +310.5% |
Q3 2021 | $630,000 | +2000.0% | 70,000 | +2700.0% | 0.02% | +1800.0% |
Q2 2021 | $30,000 | -95.2% | 2,500 | -93.8% | 0.00% | -91.7% |
Q4 2020 | $624,000 | +65.1% | 40,000 | 0.0% | 0.01% | -14.3% |
Q3 2020 | $378,000 | – | 40,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
EMC Capital Management | 48,992 | $765,000 | 0.58% |
Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |